Research Projects
External Funded Research Projects – Ongoing
| Year of Commencement | Title of the Project | Principal Investigator | Co-investigator | Funding Agency | Amount (Rs) |
|---|---|---|---|---|---|
| 2019 | Role of polysaccharides in the prevention of radiation induced intestinal injury | Vidya S. M., NMAMIT, Nitte - 574110 | Dr. Murali BadanthadkaNUCARE, NGSMIPS | Govt. of India, BRNS, Mumbai | 27,72,600 |
Internal Funded Research Projects:
| Year of Commencement | Title of the Project | Principal Investigator | Funding Agency | Amount (Rs) |
|---|---|---|---|---|
| 2017 | Effect of malnutrition and heavy metal exposure on chemical induced carcinoma in male balb/c mice | Dr. Murali Badanthadka, NUCARE, NGSMIPS | Nitte (Deemed to be University) | 85,000/ |
| 2012 | Effect of protein malnutrition on drug and alcohol interaction in mice model | Dr. Murali Badanthadka, NUCARE, NGSMIPS | Nitte (Deemed to be University) | 1,20,000/ |
Details of Consultancy Research Projects
| Year | Principle Investigator | Client Organization | Title of Project |
|---|---|---|---|
| 2016 - 17 | Dr. Murali Badanthadka | Bhami’s Research Laboratories Pvt. Ltd, Mangalore | Comparative pharmacokinetic study in rats |
| 2017 - 18 | Dr. Murali Badanthadka | Sahasraksha Vaidya Shala, Ukkinadka, Kerala | Evaluation of anticancer activity of ayurvedic preparations |
| 2017 -18 | Dr. Murali Badanthadka | Atrimed Biotech LLP. Bangalore | Evaluation of anti-psoriatic activity of formulations |
| 2018 - 19 | Dr. Murali Badanthadka | Atrimed Pharmaceuticals PVT Ltd. Bangalore | Acute and sub-acute oral toxicity study of AtrKin-1 |
| 2018 - 19 | Dr. Murali Badanthadka | Tarushi Formulations LLP. Gujarat | Evaluation of antidiabetic activity of herbal product in type-II diabetes model |
| 2018 - 19 | Dr. Murali Badanthadka | BIRAC Grant No. BT/ AIR0337/PACE-13/17 (NMAMIT, Nitte) | Evaluation of anti-venom potency of identified molecules from plant source |
| 2019 - 20 | Dr. Murali Badanthadka | Atrimed Pharmaceuticals PVT Ltd. Bangalore | Acute and sub-acute oral toxicity study of AtrKin-2 |
| 2019 - 20 | Dr. Murali Badanthadka | Atrimed Pharmaceuticals PVT Ltd. Bangalore | Acute and sub-acute oral toxicity study of AtrKin-3 |
| 2019 - 20 | Dr. Murali Badanthadka | Atrimed Pharmaceuticals PVT Ltd. Bangalore | Acute and sub-acute oral toxicity study of AtrKin-4 |
| 2019 - 20 | Dr. Murali Badanthadka | Atrimed Biotech LLP. Bangalore | Evaluation of anti-psoriatic activity of formulations |
| 2020 - 21 | Dr. Murali Badanthadka | Atrimed Biotech LLP. Bangalore | Evaluation of antidiabetic activity of herbal product in type-II diabetes model using Wistar rat (Proof of concept study) |
| 2020 - 21 | Dr. Murali Badanthadka | Atrimed Biotech LLP. Bangalore | Evaluation of anti-venom potency of herbal formulation and selected molecules. |
| 2020 - 21 | Dr. Murali Badanthadka | Atrimed Pharmaceuticals PVT Ltd. Bangalore | Acute and sub-acute oral toxicity study of AtrKin-5 |
| 2020 - 21 | Dr. Murali Badanthadka | ATRIMED BIOTECH LLP, Bangalore | Acute and sub-acute oral toxicity study of AtrKin-6-(Atri-CoV-452) |
| 2020 - 21 | Dr. Murali Badanthadka | BIRAC Grant No. BT/ AIR0337/PACE-13/17 (NMAMIT, Nitte) | Evaluation of anti-venom potency of identified molecules from plant source |
| 2020 - 21 | Dr. Murali Badanthadka | ATRIMED BIOTECH LLP, Bangalore | Evaluation of antihypercholesterolemic property of herbal products in Wistar rats. |
| 2020 - 21 | Dr. Murali Badanthadka | ATRIMED BIOTECH LLP, Bangalore | Acute and sub-acute oral toxicity study of AtrKin-7 (S-5) |
| 2021 - 22 | Dr. Murali Badanthadka | ATRIMED BIOTECH LLP, Bangalore | Acute and sub-acute oral toxicity study of AtrKin-8 (Atri-CoV-E14) |
| 2021 - 22 | Dr. Murali Badanthadka | ATRIMED BIOTECH LLP, Bangalore | Acute and sub-acute oral toxicity study of AtrKin-9 (ATRI-E107) |
| 2021 - 22 | Dr. Murali Badanthadka | SahasrakshaVaidya Shala, Ukkinadka, Kerala | Evaluation of analgesic, anti-inflammatory and anti-arthritic property of herbal product using animal models |
| 2021 - 22 | Dr. Murali Badanthadka | ATRIMED BIOTECH LLP, Bangalore | Acute and sub-acute oral toxicity study of AtrKin-10 (P-43M) |
| 2022 - 23 | Dr. Murali Badanthadka | Tarushi Formulations LLP. Gujarat | Evaluation of antihelminthic activity of kruminom syrup in earthworm and tubifex |
| 2022 - 23 | Dr. Murali Badanthadka | SahasrakshaVaidya Shala, Ukkinadka, Kerala | To conduct single dose and 28 day repeated-dose oral toxicity study for Arthralgex (UPAIN-1) using Wistar rats |
Details of Collaborative Research Projects
| Year | Title of Project | Principle Investigator | Co-investigator | Funding Agency | Amount (Rs) |
|---|---|---|---|---|---|
| 2017 | Evaluation of anticancer potency of nanoparticulate formulations | Dr. Mayur M. Patel Institute of Pharmacy, Nirma University, Gujarat - 382481, India |
Dr. Murali Badanthadka NUCARE, NGSMIPS |
Nirma University, Gujarat | 66,200 |
| 2019 | Purification and Therapeutic potential of Lubricin derived from Synovium Mesenchymal Stem Cells for Osteoarthritis | Dr. Shama Rao Research Assistant KSHEMA |
Dr. Murali Badanthadka NUCARE, NGSMIPS |
NITTE (Deemed to be University) | 3,00,000 |
| 2019 | Biology and toxicity study of Puffer fish Lagocephalus inermis, explored from Karnataka Cost | Dr. Sujitha Thomas Central Marine Fisheries Research Institute, Mangalore | Dr. Murali Badanthadka NUCARE, NGSMIPS | National Innovations on Climate Resilient Agriculture (NICRA), ICAR | 12,00,000 |
